Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, chronic cutaneous lupus erythematosus disease characterized by red or violaceous, initially pruritic (evolving to painful) papules and plaques located on acral areas (especially dorsal aspects of fingers and toes, while the nose and ear involvement is uncommon), exacerbated by cold and damp conditions, with fissuring and ulceration occasionally observed. Coexistence of discoid lupus erythematosus lesions elsewhere on the body and occasional progression to systemic lupus erythematosus may be associated. Histological examination and direct immunofluorescence studies reveal nonspecific inflammatory lupus erythematosus changes while results of cryoglobulin and cold agglutinin studies are negative.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for chilblain lupus.
35 publications have been identified in PubMed for chilblain lupus. Research spans Case Report / Case Series (48%), Basic Science / Preclinical (26%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 | 48% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:46 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
8 |
26% |
Research summaries | 5 | 16% |
Other research | 2 | 6% |
Clinical study results | 1 | 3% |
Hosseini SA (2026). [PMID: 31335009](https://pubmed.ncbi.nlm.nih.gov/31335009/). *Unknown Journal*. [Basic Science / Preclinical]
Seward AH (2026). [PMID: 41938595](https://pubmed.ncbi.nlm.nih.gov/41938595/). *JAAD Case Rep*. [Case Report / Case Series]
Han L (2026). [PMID: 41564501](https://pubmed.ncbi.nlm.nih.gov/41564501/). *Bioorg Med Chem*. [Basic Science / Preclinical]
Kim K (2026). [PMID: 41621945](https://pubmed.ncbi.nlm.nih.gov/41621945/). *J Rheumatol*. [Basic Science / Preclinical]
Velaoras AT (2026). [PMID: 42125077](https://pubmed.ncbi.nlm.nih.gov/42125077/). *JAAD Case Rep*. [Case Report / Case Series]
Muntaner-Virgili C (2026). [PMID: 42216772](https://pubmed.ncbi.nlm.nih.gov/42216772/). *J Eur Acad Dermatol Venereol*. [Other]
Israr Ul Haq M (2026). [PMID: 41822629](https://pubmed.ncbi.nlm.nih.gov/41822629/). *Cureus*. [Case Report / Case Series]
Perazzolli G (2026). [PMID: 41625144](https://pubmed.ncbi.nlm.nih.gov/41625144/). *SAGE Open Med Case Rep*. [Case Report / Case Series]
Hao W (2026). [PMID: 41939917](https://pubmed.ncbi.nlm.nih.gov/41939917/). *Front Immunol*. [Case Report / Case Series]
Bot A (2026). [PMID: 41028170](https://pubmed.ncbi.nlm.nih.gov/41028170/). *Nat Rev Drug Discov*. [Review / Meta-Analysis]